Quick Links |
Thursday |
Friday |
Saturday |
Tuesday, November 16, 2021 |
|
GENERAL INFORMATION |
|
8:30am - 3:45pm |
AMP Reference Materials ForumSatellite EventsShort Course |
11:30am - 6:00pm |
Board of Directors Meeting (Invitation Only) |
4:00pm - 7:00pm |
Attendee, Speaker, and Exhibitor Registration and Check-In |
6:30pm |
Board of Directors Dinner (Invitation Only) |
Wednesday, November 17, 2021 |
|
GENERAL INFORMATION |
|
7:00am - 5:00pm |
Attendee, Speaker, and Exhibitor Registration and Check-In |
7:30am - 3:00pm |
GetAMPed! (Separate Registration) |
8:00am - 7:00pm |
Committee Meetings (Invitation Only) |
8:00am - 5:00pm |
Corporate Workshop Day (No Registration Required!) |
1:30pm - 4:30pm |
JMD Editorial Board Meeting (Invitation Only) |
5:00pm - 6:00pm |
Volunteer Appreciation Reception (Invitation Only) |
7:00pm - 8:00pm |
Trainee Networking Hour |
Thursday, November 18, 2021 |
|
GENERAL INFORMATION |
|
6:30am - 8:00am |
Poster Set-Up |
7:00am - 5:00pm |
Attendee, Speaker, and Exhibitor Registration and Check-In |
7:00am - 8:00am |
Continental Breakfast |
11:30am - 7:15pm |
Expo Hall Open |
6:15pm - 7:15pm |
Welcome Reception (In the Expo Hall) |
SCIENTIFIC INFORMATION |
|
7:15am - 8:45am |
Independent Satellite Symposia |
8:45am - 9:00am |
Break |
9:00am - 10:30am |
CONCURRENT SYMPOSIA SESSIONSHow to Weather the Next Pandemic: Lessons Learned from the COVID-19 EUA ProcessPanel Discussion Jasmine Chaitram, MPH, MT (ASCP), CDC Division of Laboratory Systems, Atlanta, GA, USA Karen L. Kaul, MD, PhD, NorthShore University Health System, Evanston, IL, USA Timothy Stenzel, MD, PhD, US Food and Drug Administration, Rockville, MD, USA New Insights into Cancer Biology from DNA Mutational SignaturesThe Repertoire of Mutational Signatures in Human Cancer Ludmil B. Alexandrov, PhD, University of California San Diego, La Jolla, CA, USA Ongoing efforts to identify causes of currently unexplained signatures Serena Nik-Zainal, MD, PhD, University of Cambridge, Cambridge, United Kingdom |
10:30am - 10:45am |
Break |
10:45am - 11:30am |
AMP Working Group Meetings |
11:30am - 11:45am |
Break |
11:45am - 12:00pm |
Opening Remarks |
12:00pm - 1:00pm |
AMP Award for Excellence in Molecular Diagnostics: Presentation and LectureCRISPRology: Science and Ethics of Genome Editing Jennifer Doudna, PhD, University of California, Berkeley, CA, USA |
1:00pm - 2:15pm |
General Lunch - Visit Expo Hall and View PostersNetworking Lunches (Schedule)Innovation Spotlight Stage (Schedule) |
2:15pm - 3:30pm |
CONCURRENT BREAKOUT SESSIONSLow Coverage Whole Genome SequencingLow-pass Genome Sequencing and Polygenic Risk Scores Joe Pickrell, Gencove, New York, NY, USA Low Coverage Whole Genome Sequencing Julian Homburger, PhD, Color Health, Alamo, CA, USA Alternative Perspectives to Multi-omics Single-cell AnalysisAlternative Perspectives to Multi-omics Single-cell Analysis Robert B. Faryabi, PhD, MSc, University of Pennsylvania School of Medicine, Philadelphia, PA, USA The Changing Landscape of Reimbursement for Pathology Clinical Consultation and Impact on Interpretation of Tumor GenomicsCurrent landscape of coding and reimbursement for tumor genomics interpretation and clinical correlation and consultation Samuel K. Caughron, MD, MAWD Pathology Group, Lenexa, KS, USA Tracking the Global Spread of Mutli-Drug Resistant OrganismsThe Genomics, Evolution, and Spread of Drug-resistant Neisseria gonorrhoeae Yonatan Grad, MD, PhD, Harvard Chan School of Public Health, Boston, MA, USA Tracking the Global Spread of Mutli-Drug Resistant Organisms Paul J. Planet, MD, PhD, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, USA New Developments in Mitochondrial DNA Variant Identification and ClassificationMitochondrial DNA Variant Classification and MITOMAP Marni J. Falk, MD, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA |
3:30pm - 5:15pm |
Coffee Break - Visit Expo Hall and View PostersInnovation Spotlight Stage (Schedule) |
5:15pm - 6:15pm |
PLENARY SESSIONMRD for Lymphoma Beyond ImmunoglobulinAsh Alizadeh, MD, PhD, Color Health, Stanford, CA, USA |
6:15pm - 7:15pm |
Welcome Reception (In the Expo Hall) |
Friday, November 19, 2021 |
|
GENERAL INFORMATION |
|
7:00am - 5:00pm |
Attendee, Speaker, and Exhibitor Registration and Check-In |
7:00am - 8:00am |
Continental Breakfast |
9:00am - 4:00pm |
Expo Hall Open |
SCIENTIFIC INFORMATION |
|
7:30am - 8:30am |
TARGETED TOPICSCase StudiesPerspectives on Tumor Mutational Burden: An Update from the AMP TMB Working GroupLarissa V. Furtado, MD, St. Jude Children’s Research Hospital, Memphis, TN, USA Lauren Ritterhouse, MD, PhD, Massachusetts General Hospital, Andover, MA, USA Utilization of NGS Testing in Cytopathology SamplesHamza N. Gokozan, MD, Weill Cornell Medicine, New York, NY, USA Mitochondrial DNA as Clonal Markers to Infer and Track Clonal MosaicismVijay G. Sankaran, MD, PhD, Boston Children's Hospital/ Harvard Medical School, Boston, MA, USA |
8:30am - 8:45am |
Break |
8:45am - 9:45am |
PLENARY SESSIONHow Far are We from an HIV Cure? Implications for Molecular DiagnosticsPathways Towards an HIV Cure? Implications for Molecular Diagnostics Deborah Persaud, MD, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
9:45am - 10:45am |
Coffee Break - Visit Expo Hall and View Posters(Even-numbered posters Attended) Innovation Spotlight Stage (Schedule) |
10:45am - 12:15pm |
CONCURRENT BREAKOUT SESSIONSNegotiating in a Hostage Situation: Tips to Keep Your Lab Financially Solvent During COVID-19 and the Next PandemicMatt Charles, MPH, Northshore University HealthSystem, Chicago, IL, USA Donna Wolk, Geisinger, Danville, PA , USA Promises & Pitfalls of EHR-based Variant ReanalysisVariant Reclassification and Reinterpretation - Challenges and Opportunities in Current and Future EHR Usability and Function Alexis Carter, MD, Children’s Healthcare of Atlanta, Atlanta, GA, USA Improvement and Challenges of EHR System and Integration of Genomic Data Alexis Carter, MD, Children’s Healthcare of Atlanta, Atlanta, GA, USA Considerations for the Optimal Detection of Clinically Relevant Fusions in Solid TumorsOverview of the Various Methodologies for Fusion Detection in a Clinical Laboratory John Iafrate, MD, PhD, Massachusetts General Hospital, Boston, MA, USA Clinical Fusion Detection Approaches and Methodologies Susan Hsiao, MD, PhD, Columbia University Medical Center, New York, NY, USA Use of in Silico Data for Pipeline Development/ValidationSabah Kadri, Lurie Children's Hospital of Chicago, Chicago, IL, USA Genetic Healthcare DisparitiesSocial Implications of Genetic Diagnosis and Therapies John Carpten, PhD, University of Southern California, Los Angeles, CA, USA Enabling Precision Medicine for Diverse Populations Lucia Hindorff Lack of Diversity in Genomics and Implications for Clinical Genetics Alice B. Popejoy, PhD, University of California, Davis, Sacramento, CA, USA |
12:15pm - 1:30pm |
General Lunch - Visit Expo Hall and View PostersNetworking Lunches (Schedule)Innovation Spotlight Stage (Schedule) |
1:30pm - 3:00pm |
CONCURRENT SYMPOSIA SESSIONSPerspectives on the Applications of SARS CoV-2 Genome SequencingPanel Discussion Jennifer Dien Bard, PHD, Children's Hospital of Los Angeles; Keck School of Medicine, USC, South Pasadena, CA, USA Kirsten St. George, M.App.Sc., PHD, Department of Health, Wadsworth Center, Albany, NY, USA Pavitra Roychoudhury Applications of Therapeutic Gene EditingDevelopment and Application of Genome Editing Technologies Fyodor Urnov, PhD, University of California, Berkeley, CA, USA Gene Editing for the Treatment of Red Blood Cell Disorders Haydar Frangoul, MD, Sarah Cannon Center for Blood Cancer, Nashville, TN, USA |
3:00pm - 4:00pm |
Coffee Break - Visit Expo Hall and View PostersInnovation Spotlight Stage (Schedule) |
4:00pm - 5:00pm |
PLENARY SESSIONAt the Intersection of Precision Medicine and Machine LearningEliezer Van Allen, MD, Dana Farber Cancer Institute, Brookline, MA, USA |
5:00pm - 5:15pm |
Break |
5:15pm - 6:15pm |
Business Meeting and Awards Session(Open to All Registered Attendees) |
7:00pm - 10:30pm |
Social Event(Separate Registration) |
Saturday, November 20, 2021 |
|
GENERAL INFORMATION |
|
7:00am - 2:00pm |
Attendee, Speaker, and Exhibitor Registration and Check-In |
7:00am - 8:00am |
Continental Breakfast |
9:00am - 1:30pm |
Expo Hall Open |
12:30pm - 1:30pm |
Poster Removal |
SCIENTIFIC INFORMATION |
|
7:30am - 8:30am |
TARGETED TOPICSCase StudiesPlatform Presentations of Selected Technical Topics AbstractsTT34 - Qualitative Detection of EGFR mutations (exons 18–21) in Lung cancer using Idylla Platform Meenakshi Mehrotra, Icahn School of Medicine at Mount Sinai TT25 - Urine-Based Testing for Mitochondrial Diseases: An Alternative to Invasive Muscle Biopsies? Taylor Ashworth, Mayo Clinic TT12 - Validation of Targeted Next-Generation Sequencing of Cell-Free DNA from Stored Cerebrospinal Fluid Specimens for the Detection of Somatic Variants in Cancer Involving the Leptomeninges Alexander Neil, Brigham and Women's Hopsital Difficult to Sequence Regions in the GenomeDescription of Hard to Sequence Regions Justin M. Zook, PhD, NIST, Gaithersburg, MD, USA Informatics Solutions to Difficult to Sequence Regions Karen Miga Advanced Sequencing Applications in the Public Health LaboratoryMolecular Streptococcus Pneumoniae Serotyping Sara Vetter, PhD, D(ABMM), Minnesota State Public Health Laboratory, St. Paul, MN, USA How NGS Is Used for Outbreak Detection Heather Carleton, CDC, Atlanta, GA, USA |
8:30am - 8:45am |
Break |
8:45am - 9:45am |
PLENARY SESSIONAdvances in Clinical Applications for Complex Genetic Disorders |
9:45am - 10:45am |
Coffee Break - Visit Expo Hall and View Posters(Odd-numbered posters Attended)
Innovation Spotlight Stage (Schedule) |
10:45am - 12:15pm |
CONCURRENT BREAKOUT SESSIONSMolecular Diagnostics in the Community Hospital: How to Offer Complete and Up to Date TestingOverview of Provision and Utilization of Molecular Testing in Community Cancer Centers, Ideally from an Individual Involved in the Association of Community Cancer Centers Tabetha Sundin, PhD, HCLD (ABB), MB (ASCP)CM, AstraZeneca, Middletown, MD, USA Experience from Molecular Pathologists Running Laboratories in a Community or Non-academic Setting, Discussing How They've Chosen What Types of Molecular Testing to Provide and How They Have Established Their Role in the Larger Molecular Laboratory Ecosystem Michelle Shiller, DO, AP/CP, MGP, Baylor Scott & White Health, Dallas, TX, USA Novel Insights into Clonal HematopoiesisLink Between Cancer Therapy and Clonal Hematopoiesis Ahmet Zehir, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA Rationale for screening stem cell donors for clonal hematopoiesis Lukasz Gondek Rationale for not screening stem cell donors for clonal hematopoiesis Coleman Lindsley, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA Pharmacogenomic Testing Across PopulationsPharmacogenomics Implementation Across Populations in North America Deepak Voora, MD, Duke University, Durham, NC, USA Implementation of Pharmacogenetics in Clinical Care: an EU perspective Ron HN Van Schaik, PhD, Erasmus MC, Rotterdam, Zuid-Holland, Netherlands Pharmacogenomics in Pediatrics Laura B. Ramsey, PhD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA Cool New Tech for At-Home TestingRapid, Point-of-Care Diagnostics Catherine Klapperich, PhD, Boston University, Brookline, MA, USA Cool New Tech for At-Home Testing Jonathan Posner Cool New Tech for At-Home Testing Melanie Ott, MD, PhD, Gladstone Institute of Virology and UCSF, San Francisco, CA, USA |
12:15pm - 1:30pm |
General Lunch - Visit Expo Hall, and View PostersNetworking Lunches (Schedule)Innovation Spotlight Stage (Schedule) |
1:30pm - 2:30pm |
CONCURRENT BREAKOUT SESSIONSPlatform Presentations of Selected Abstracts Abstracts are selected by the Program Committee Platform Presentations of Selected Genetics AbstractsG04 - A Comparison of Strategies for the Collection and Use of Phenotypic Information in the North Carolina Clinical Genomic Evaluation by Next-Generation Exome Sequencing 2 (NCGENES 2) Study Shannon McNulty, University of NC, Chapel Hill G28 - Implementing a Genomic Population Health Screening Program in Primary Care: Lessons Learned Robert Wildin, University of Vermont Larner College of Medicine G23 - COVID19 symptoms vary by HLA haplogroup in a well typed crowd cohort Jeffrey Rosenfeld, Rutgers Cancer Institute of New Jersey G01 - A Novel Machine Learning Plus Whole Methylome Approach for the Diagnosis of Germline Disorders Linda Hasadsri, Mayo Clinic Platform Presentations of Selected Hematopathology AbstractsH27 - Comprehensive Genomic Profiling Discovers Recurrent Mutations and Copy Number Alterations of T-cell Large granular Lymphocytic Leukemia Jinjuan Yao, Memorial Sloan Kettering Cancer Center H19 - Clonal cytogenetic abnormalities in donor-derived cells after sex mismatched allogenic stem cell transplantation Gokce Toruner, UT MD Anderson Cancer Center H22 - Clinicopathologic Features of Acute Myeloid Leukemia with NUP98 Rearrangement Maria Magallanes Hoyos, Oregon Health and Science University H20 - AML with germline DDX41 mutations is a distinct clinicopathologically and molecularly defined entity with a sub-acute course and favorable outcome Peng Li, University of Utah/ARUP Labs Platform Presentations of Selected Infectious Diseases AbstractsID20 - Development and Six-Month Evaluation of SARS-CoV-2 Wastewater Surveillance in a Low-Prevalence Rural Region (The RECOVER Project) Diana Toledo, Dartmouth-Hitchcock Medical Center ID06 - Genetic variation in circulating SARS-CoV-2 is detected by RT-PCR/MALDI-TOF diagnostic targets Matthew Hernandez, Icahn School of Medicine at Mount Sinai ID24 - Fragment Analysis for Scalable Detection of SARS-CoV-2 Variants of Concern Jeffrey SoRelle, UT Southwestern University Platform Presentations of Selected Informatics AbstractsI04 - CNViz: an R/Shiny Application For Interactive Copy Number Variant Visualization in Cancer Rebecca Greenblatt, Perelman School of Medicine at the University of Pennsylvania I08 - CloneSeer: Sequence Alignment-Based Detection and Quantification of Lymphoma Sub-Clones Eitan Halper-Stromberg, Johns Hopkins University I13 - UNISON: A UNIfied SOmatic CalliNg (UNISON) pipeline for identifying Clonal Hematopoiesis of Indeterminate Potential Eric Klee, Mayo Clinic I02 - Human Leukocyte Antigen Typing of Patients with Myeloid Malignancies by Whole Genome Sequencing Andrew Hughes, Washington University School of Medicine Platform Presentations of Selected Solid Tumors AbstractsST71 - Targeted next-generation sequencing of biliary tract specimens from patients with primary sclerosing cholangitis improves the early detection of cholangiocarcinoma Aatur Singhi, University of Pittsburgh Medical Center ST08 - PurIST Pancreatic Cancer Classifier: A 16-RNA Expression Signature Array Comparable to RNAseq Margaret Gulley, University of NC, Chapel Hill ST74 - Optical genome mapping for the chromosomal characterization of solid tumors Ravindra Kolhe, Augusta University ST57 - Translating Transcriptome Sequencing into Clinical Diagnostics for Pediatric Solid Tumors Feng Xu, Children's Hospital of Philadelphia |
2:30pm - 2:45pm |
Break |
2:45pm - 4:15pm |
CONCURRENT SYMPOSIA SESSIONSLiquid Biopsy and MRDUse of Patient Specific Panels for MRD Detection Viktor Adalsteinsson, PhD, Broad Institute of MIT and Harvard, Wakefield, MA, USA Use of Methylation Signatures for MRD Detection Dan Landau, MD, PhD, Weill Cornell Medicine, New York, NY, USA New Applications of CAR T-CellsCAR T-cell therapies for autoimmune diseases Michael Milone “Mechanisms of CAR T cells” Macela Maus, MD, PhD, Massachusetts General Hospital East, Charlestown, MA, USA Practical Issues with Quantitative Molecular Testing for Infectious DiseasesValidation of Samples Shared Between Molecular and Other Testing Platforms Rebecca Harris, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, PA, USA CMV Viral Load Testing Randall Hayden, MD, St. Jude Children's Research Hospital, Memphis, TN, USA Practical Considerations to Optimize Algorithmic Testing for the Diagnosis of HIV Blake W. Buchan, PhD, Medical College of Wisconsin, Milwaukee, WI, USA |
4:15pm - 4:30pm |
Break |
4:30pm - 5:30pm |
PLENARY SESSIONMutational Processes in Cancer Cells and Normal CellsMutational Signature Analysis and its Application to the Clinic Peter J. Park, PhD, Harvard Medical School, Boston, MA, USA |
5:30pm - 5:45pm |
Closing Remarks |